Skip to main navigation Skip to search Skip to main content

Axi-STS: A Clinicopathological phase II study of axitinib in patients with advanced angiosarcoma and other soft tissue sarcomas.

Project Details

Short titleAxi-STS: A Clinicopathological phase II study of axitinib in patients with advanced angiosarcoma and other soft tissue sarcomas.
StatusFinished
Effective start/end date1/06/10 → 31/12/25

Funding

  • PFIZER LIMITED
  • Cancer Research UK